Abstract
A library of 4-(3-acyl- or carbamoylaminoimidazo[1,2-a]pyridin-2-yl)benzamides (8) was synthesized on solid phase. A suitably protected core acid (1) was synthesized in multigram quantity using previously published procedure and used as the acylating reagent for modifying a set of AMEBA resins. Subsequent liberation of the amino group (using a novel hydrazine procedure) and its acylation or carbamoylation provided, after cleavage, final products in higher chemical yields and purities compared to known protocols that include formation of the imidazo[1,2-a]pyridine core on solid support.
Keywords: Imidazo[1,2-a]pyridines, solid phase, combinatorial libraries, isocyanide-based multi-component reactions, privileged structures
Letters in Organic Chemistry
Title: Development of Privileged Groebke-Blackburn-Type 4-(3-aminoimidazo [1,2-a]pyridin-2-yl)benzoic Acid Core into a Combinatorial Library on Solid Phase
Volume: 6 Issue: 6
Author(s): Yuri Sandulenko, Alexander Komarov and Mikhail Krasavin
Affiliation:
Keywords: Imidazo[1,2-a]pyridines, solid phase, combinatorial libraries, isocyanide-based multi-component reactions, privileged structures
Abstract: A library of 4-(3-acyl- or carbamoylaminoimidazo[1,2-a]pyridin-2-yl)benzamides (8) was synthesized on solid phase. A suitably protected core acid (1) was synthesized in multigram quantity using previously published procedure and used as the acylating reagent for modifying a set of AMEBA resins. Subsequent liberation of the amino group (using a novel hydrazine procedure) and its acylation or carbamoylation provided, after cleavage, final products in higher chemical yields and purities compared to known protocols that include formation of the imidazo[1,2-a]pyridine core on solid support.
Export Options
About this article
Cite this article as:
Sandulenko Yuri, Komarov Alexander and Krasavin Mikhail, Development of Privileged Groebke-Blackburn-Type 4-(3-aminoimidazo [1,2-a]pyridin-2-yl)benzoic Acid Core into a Combinatorial Library on Solid Phase, Letters in Organic Chemistry 2009; 6 (6) . https://dx.doi.org/10.2174/157017809789124957
DOI https://dx.doi.org/10.2174/157017809789124957 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
From the Explored to the Unexplored: Computer-Tailored Drug Design Attempts in the Discovery of Selective Caspase Inhibitors
Combinatorial Chemistry & High Throughput Screening Vagotomy and Gastric Tumorigenesis
Current Neuropharmacology Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson’s Disease
Current Neuropharmacology The Interactions Between Diabetes Mellitus and Myelodysplastic Syndromes: Current State of Evidence and Future Directions
Current Diabetes Reviews Anticonvulsant and Neurotoxicity Evaluation of Some N4 Phenyl Substituted Pyridyl Semicarbazones
Central Nervous System Agents in Medicinal Chemistry Toll-Like Receptors, Cytokines and the Immunotherapeutics of Asthma
Current Pharmaceutical Design An Overview on the Role of α -Synuclein in Experimental Models of Parkinson’s Disease from Pathogenesis to Therapeutics
CNS & Neurological Disorders - Drug Targets Crosstalk between IGF-1R and other Tumor Promoting Pathways
Current Pharmaceutical Design Attitudes of Infertile Couples to a Multiple Birth: A Review of theLiterature and Results from a Survey
Current Women`s Health Reviews Current Progress of Reelin in Development, Inflammation and Tissue Remodeling: From Nervous to Visual Systems
Current Molecular Medicine Protective Effect of Notoginsenoside R1 on an APP/PS1 Mouse Model of Alzheimer's Disease by Up-Regulating Insulin Degrading Enzyme and Inhibiting Aβ Accumulation
CNS & Neurological Disorders - Drug Targets Endophytes and Neurodegenerative Diseases: A Hope in Desperation
CNS & Neurological Disorders - Drug Targets Clinical Drugs that Interact with St. Johns Wort and mplication in Drug Development
Current Pharmaceutical Design Recent Developments in the Discovery of Novel Antipsychotic Agents Modualating Dopamine and Serotonin Receptors
Current Drug Targets What Fans the Fire: Insights into Mechanisms of Leptin in Metabolic Syndrome- Associated Heart Diseases
Current Pharmaceutical Design Does Calprotectin Represent a Regulatory Factor in Host Defense or a Drug Target in Inflammatory Disease?
Endocrine, Metabolic & Immune Disorders - Drug Targets Photoreorganization of 2-methyl-3-(prop-2-ynyloxy)-4H-chromen-4-ones: Synthesis of 4-methylcoumarin Derivatives
Current Organic Synthesis Nitric Oxide’s Involvement in the Spectrum of Psychotic Disorders
Current Medicinal Chemistry Dehydroepiandrosterone Treatment Alters Lipid/Phospholipid Profiles of Rat Brain and Liver Mitochondria
Current Neurovascular Research Herbal Insomnia Medications that Target GABAergic Systems: A Review of the Psychopharmacological Evidence
Current Neuropharmacology